No abstract

Introduction: Enteral nutritional therapy (ERT) is essential to restore or maintain the patient's nutritional status. However, it may not guarantee the reach of nutritional needs and may generate several complications. Aiming at better patient care, quality tools have been created as quality indicators in enteral nutritional therapy (IQTNE). Objectives: To analyze IQTNE in an intensive care unit (ICU). Methods: This was a retrospective study composed of data collected during eight months from the medical charts of patients under ERT who were admitted to an ICU of a private hospital. The IQTNE analyzed were: (1) frequency of nutritional screening; (2) frequency of days of adequate energy administration; (3) frequency of days of adequate protein administration; (4) frequency of diarrhea; (5) inadvertent output frequency of nutrition probe; (6) frequency of nutrition probe obstruction and (7) adequacy rate of volume infused over prescribed. Results: The sample included data from 122 patients under ERT with mean age of 76.9 ± 16.4 years and 29.9 ± 28.6 days of hospitalization. The IQTNE (1) showed a mean of 97.3 ± 3.1%, IQTNE (2) 88.1 ± 3.8%, IQTNE (3) 89.8 ± 4.8%, IQTNE (4) 9 , IQTNE (5) 3.9 ± 2.2%, with inadequacy in 25% of the months analyzed, IQTNE (6), 0.8% ± 1.5% and the IQTNE (7) obtained 94.3 ± 3.3% of adequacy. The observed complications negatively influenced the adequacy of the instituted ERT. Conclusion: On average, all IQTNs analyzed reached the pre-established goal; however, attention should be given to the symptoms of diarrhea and inadvertent outflow of the nutrition tube.

No abstract

We used data from the Campinas Health Survey (ISACamp 2014/15) and the Food Consumption and Nutritional Status Survey (ISACamp-Nutri 2015/16) to estimate the prevalence of the consumption of foods and beverages that contain low-calorie sweeteners (LCS) by individuals ≥10 years to estimate the dietary exposure of the population to high levels of LCS. We first estimated the prevalence of consuming LCS-containing foods and beverages and identified the top sources of LCS consumption. We then verified whether the prevalence of consumption varied according to individual-level characteristics or the presence of obesity and diabetes. Finally, we estimated the population dietary exposure to high levels of LCS and compared it with the acceptable daily intake (ADI) levels. Over 40% of the study population consumed at least one food or beverage containing LCS. Sweetened beverages, tabletop sweeteners and dairy beverages were the top contributors to the consumption of LCS. Among all age groups, education levels, and income levels, the consumption of foods and beverages containing LCS ranged from 35% to 55%. The prevalence was only slightly greater among higher income 40-59-year-olds than among other income groups and was not higher among individuals with obesity or diabetes. Although dietary exposure to LCS did not exceed the ADI levels, we identified several limitations in our ability to measure exposure to high levels of LCS. Because of these challenges and the unclear evidence linking LCS to better health outcomes, the consumption of foods and beverages containing LCS should be closely monitored.